Samuel Guan Wei Ow
Overview
Explore the profile of Samuel Guan Wei Ow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee V, Loh J, Hui F, Sundar R, Tan B, Lee M, et al.
Support Care Cancer
. 2024 Nov;
32(11):762.
PMID: 39482416
Purpose: Scalp cooling therapy (SCT) improves chemotherapy-induced alopecia (CIA), but there are few published data about its efficacy in an Asian-predominant population. We report our tertiary institution experience of SCT...
2.
Loh J, Ong P, Goh D, Puhaindran M, Vellayappan B, Ow S, et al.
Hered Cancer Clin Pract
. 2022 Jun;
20(1):23.
PMID: 35698239
Background: Peripheral Nerve Sheath Tumors (PNST) are a diverse group of mostly benign tumours uncommon in the general population. About 5-10% of PNSTs are hereditary, predominantly arising from germline variants...
3.
Yadav K, Lim J, Choo J, Ow S, Wong A, Lee M, et al.
Breast Cancer Res Treat
. 2021 Dec;
192(1):131-142.
PMID: 34928481
Purpose: Tumor angiogenesis controlled predominantly by vascular endothelial growth factor and its receptor (VEGF-VEGFR) interaction plays a key role in the growth and propagation of cancer cells. However, the newly...
4.
Wong Y, Jagmohan P, Goh Y, Putti T, Ow S, Thian Y, et al.
Insights Imaging
. 2021 Dec;
12(1):181.
PMID: 34894297
Invasive lobular carcinoma (ILC) has a greater tendency to metastasize to the peritoneum, retroperitoneum, and gastrointestinal (GI) tract as compared to invasive carcinoma of no special type (NST). Like primary...
5.
Moy B, Oliveira M, Saura C, Gradishar W, Kim S, Brufsky A, et al.
Breast Cancer Res Treat
. 2021 Apr;
188(2):449-458.
PMID: 33909203
Purpose: To characterize health-related quality of life (HRQoL) in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC) from the NALA phase 3 study. Methods: In...
6.
Chan J, Sim Y, Ow S, Lim J, Kusumawidjaja G, Zhuang Q, et al.
Endocr Relat Cancer
. 2020 Jun;
27(9):R307-R327.
PMID: 32544879
The ensuing COVID-19 pandemic poses unprecedented and daunting challenges to the routine delivery of oncological and supportive care to patients with breast cancer. Considerations include the infective risk of patients...
7.
Ho P, Ow S, Sim Y, Liu J, Lim S, Tan E, et al.
Sci Rep
. 2020 Jan;
10(1):1330.
PMID: 31992769
Breast cancer survival has improved with significant progress in treatment and disease management. However, compliance with treatment varies. Treatment guidelines for older patients are unclear. We aim to identify predictors...
8.
Ong P, Poon S, Tan K, Putti T, Ow S, Chen S, et al.
Gynecol Oncol
. 2019 Sep;
155(2):275-279.
PMID: 31481248
Objective: Clinical genetic testing to diagnose germline mutations often requires blood sample or saliva smear from a cancer-affected individual. This rules out testing in families when cancer-affected individuals are deceased....
9.
Ow S, Ong P, Lee S
PLoS One
. 2019 Mar;
14(3):e0213746.
PMID: 30875412
Background: Due to historically low uptake of genetic testing, the mutational spectrum of Asians with Hereditary Breast Cancer (HBC) is not well understood. This study sought to understand the incidence...
10.
Sundar R, Bandla A, Tan S, Liao L, Kumarakulasinghe N, Jeyasekharan A, et al.
Front Oncol
. 2017 Jan;
6:274.
PMID: 28119855
Background: Peripheral neuropathy (PN) due to paclitaxel is a common dose-limiting toxicity with no effective prevention or treatment. We hypothesize that continuous-flow limb hypothermia can reduce paclitaxel-induced PN. Patients And...